The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System*

Background: Klotho is an age suppressor protein whose brain function is unknown. Results: Klotho protects hippocampal neurons from glutamate and amyloid β-induced oxidative damage through the induction of the thioredoxin/peroxiredoxin system. Conclusion: Klotho is neuroprotective via the regulation of the redox system. Significance: Understanding the mechanism underlying Klotho-induced neuroprotection may lead to the development of novel therapeutic approaches against neurodegeneration. Generation of reactive oxygen species (ROS), leading to oxidative damage and neuronal cell death, plays an important role in the pathogenesis of neurodegenerative disorders, including Alzheimer disease. The present study aimed to examine the mechanism by which the anti-aging protein Klotho exerts neuroprotective effects against neuronal damage associated with neurodegeneration and oxidative stress. Pretreatment of rat primary hippocampal neurons and mouse hippocampal neuronal cell line HT22 with recombinant Klotho protected these cells from glutamate and oligomeric amyloid β (oAβ)-induced cytotoxicity. In addition, primary hippocampal neurons obtained from Klotho-overexpressing mouse embryos were more resistant to both cytotoxic insults, glutamate and oAβ, compared with neurons from wild-type littermates. An antioxidative stress array analysis of neurons treated with Klotho revealed that Klotho significantly enhances the expression of the thioredoxin/peroxiredoxin (Trx/Prx) system with the greatest effect on the induction of Prx-2, an antioxidant enzyme, whose increase was confirmed at the mRNA and protein levels. Klotho-induced phosphorylation of the PI3K/Akt pathway, a pathway important in apoptosis and longevity, was associated with sustained inhibitory phosphorylation of the transcription factor forkhead box O3a (FoxO3a) and was essential for the induction of Prx-2. Down-regulation of Prx-2 expression using a lentivirus harboring shRNA almost completely abolished the ability of Klotho to rescue neurons from glutamate-induced death and significantly, but not completely, inhibited cell death mediated by oAβ, suggesting that Prx-2 is a key modulator of neuroprotection. Thus, our results demonstrate, for the first time, the neuroprotective role of Klotho and reveal a novel mechanism underlying this effect.

[1]  L. Mucke,et al.  Life extension factor klotho enhances cognition. , 2014, Cell reports.

[2]  Jun-Rong Du,et al.  Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model , 2014, Neurobiology of Aging.

[3]  L. Ferrucci,et al.  Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease , 2014, Neuroscience Letters.

[4]  S. Clinton,et al.  Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood , 2013, Brain Research.

[5]  R. Uranga,et al.  Enhanced Phosphatidylinositol 3-kinase (PI3K)/Akt Signaling Has Pleiotropic Targets in Hippocampal Neurons Exposed to Iron-induced Oxidative Stress* , 2013, The Journal of Biological Chemistry.

[6]  K. Rosenblatt,et al.  Klotho Ameliorates Chemically Induced Endoplasmic Reticulum (ER) Stress Signaling , 2013, Cellular Physiology and Biochemistry.

[7]  S. Biswas,et al.  FoxO3a is activated and executes neuron death via Bim in response to β-amyloid , 2013, Cell Death and Disease.

[8]  H. Tedeschi,et al.  Hippocampal gene expression dysregulation of Klotho, nuclear factor kappa B and tumor necrosis factor in temporal lobe epilepsy patients , 2013, Journal of Neuroinflammation.

[9]  H. Tedeschi,et al.  Hippocampal gene expression dysregulation of Klotho, nuclear factor kappa B and tumor necrosis factor in temporal lobe epilepsy patients , 2013, Journal of Neuroinflammation.

[10]  A. Giordano,et al.  Neuroprotective effects of PrxI over‐expression in an in vitro human Alzheimer's disease model , 2013, Journal of cellular biochemistry.

[11]  Ø. Bruserud,et al.  PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells , 2013, Cell Death and Disease.

[12]  J. Luebke,et al.  The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS , 2013, The Journal of Neuroscience.

[13]  D. Rosene,et al.  Promoter methylation and age-related downregulation of Klotho in rhesus monkey , 2012, AGE.

[14]  Manisha N. Patel,et al.  Thioredoxin Reductase Deficiency Potentiates Oxidative Stress, Mitochondrial Dysfunction and Cell Death in Dopaminergic Cells , 2012, PloS one.

[15]  M. Glicksman,et al.  Small-molecule Klotho enhancers as novel treatment of neurodegeneration. , 2012, Future medicinal chemistry.

[16]  Feng Yan,et al.  Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathway. , 2012, Antioxidants & redox signaling.

[17]  Xinran Liu,et al.  Nuclear localization of Klotho in brain: an anti-aging protein , 2012, Neurobiology of Aging.

[18]  P. Li,et al.  Glutamate Induces Mitochondrial Dynamic Imbalance and Autophagy Activation: Preventive Effects of Selenium , 2012, PloS one.

[19]  M. Smith,et al.  Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity , 2012, Cell Death and Disease.

[20]  I. Mook‐Jung,et al.  Mitochondria-Specific Accumulation of Amyloid β Induces Mitochondrial Dysfunction Leading to Apoptotic Cell Death , 2012, PloS one.

[21]  Hong Zhu,et al.  The antioxidant enzyme peroxiredoxin and its protective role in neurological disorders , 2012, Experimental biology and medicine.

[22]  Young Ju Lee,et al.  Peroxiredoxin I regulates the component expression of γ-secretase complex causing the Alzheimer's disease , 2011, Laboratory animal research.

[23]  P. Reddy,et al.  Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.

[24]  A. Melo,et al.  Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives , 2011, Oxidative Medicine and Cellular Longevity.

[25]  W. Sellers,et al.  FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF‐23 signaling and regulating FGF‐23 expression in bone , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Douglas L. Rosene,et al.  Promoter methylation and age-related downregulation of Klotho in rhesus monkey , 2011, AGE.

[27]  M. Rowan,et al.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites , 2011, Nature communications.

[28]  G. Kim,et al.  Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage , 2011, Neurobiology of Aging.

[29]  G. Hardingham,et al.  CNS peroxiredoxins and their regulation in health and disease. , 2011, Antioxidants & redox signaling.

[30]  N. Plesnila,et al.  Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons , 2011, Cell Death and Differentiation.

[31]  O. Togao,et al.  Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice* , 2011, The Journal of Biological Chemistry.

[32]  P. Seth,et al.  Tetrahydrocurcumin confers protection against amyloid &bgr;-induced toxicity , 2011, Neuroreport.

[33]  Joshua A. Smith,et al.  Post-Treatment with Voltage-Gated Na+ Channel Blocker Attenuates Kainic Acid-Induced Apoptosis in Rat Primary Hippocampal Neurons , 2010, Neurochemical Research.

[34]  H. Bading,et al.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.

[35]  Paul M Matthews,et al.  Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. , 2010, Brain : a journal of neurology.

[36]  B. Zhu,et al.  Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. , 2010, Free radical biology & medicine.

[37]  K. Kwon,et al.  Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways , 2010, Journal of clinical neurology.

[38]  S. Galas,et al.  Klotho interferes with a novel FGF-signalling pathway and insulin/Igf-like signalling to improve longevity and stress resistance in Caenorhabditis elegans , 2010, Aging.

[39]  G. Farrugia,et al.  Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastric dysfunction in progeric mice , 2010, The Journal of physiology.

[40]  K. Kang,et al.  Growth‐stimulatory effect of resveratrol in human cancer cells , 2010, Molecular carcinogenesis.

[41]  S. Hecht,et al.  Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  G. Johnson,et al.  The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease , 2010, Journal of bioenergetics and biomembranes.

[43]  K. Yoo,et al.  Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage. , 2010, Free radical biology & medicine.

[44]  E. Masliah,et al.  Molecular mechanisms of neurodegeneration in Alzheimer's disease. , 2010, Human molecular genetics.

[45]  M. Kuro-o.  Klotho and aging. , 2009, Biochimica et biophysica acta.

[46]  P. Reddy,et al.  Role of Mitochondria in Neurodegenerative Diseases: Mitochondria as a Therapeutic Target in Alzheimer's Disease , 2009, CNS Spectrums.

[47]  R. Ph.  Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. , 2009 .

[48]  S. Cha,et al.  Regulation of Renal Outer Medullary Potassium Channel and Renal K+ Excretion by Klotho , 2009, Molecular Pharmacology.

[49]  F. Khuri,et al.  LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins. , 2008, Cancer research.

[50]  E. Bigio,et al.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers , 2008, Neurobiology of Aging.

[51]  K. Rosenblatt,et al.  Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1 , 2008, Proceedings of the National Academy of Sciences.

[52]  T. Gotow,et al.  Morphological and biochemical signs of age-related neurodegenerative changes in klotho mutant mice , 2008, Neuroscience.

[53]  A. Brunet,et al.  FoxO transcription factors in the maintenance of cellular homeostasis during aging. , 2008, Current opinion in cell biology.

[54]  P. Ghazal,et al.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses , 2008, Nature Neuroscience.

[55]  S. Leeman,et al.  Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 , 2007, Proceedings of the National Academy of Sciences.

[56]  R. Koren,et al.  Enamel matrix derivative protects human gingival fibroblasts from TNF‐induced apoptosis by inhibiting caspase activation , 2007, Journal of cellular physiology.

[57]  W. Fischer,et al.  Increase in Expression Levels and Resistance to Sulfhydryl Oxidation of Peroxiredoxin Isoforms in Amyloid β-Resistant Nerve Cells* , 2007, Journal of Biological Chemistry.

[58]  G. Gibson,et al.  Oxidative Stress and Transcriptional Regulation in Alzheimer Disease , 2007, Alzheimer disease and associated disorders.

[59]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[60]  S. Murakami.  Stress resistance in long-lived mouse models , 2006, Experimental Gerontology.

[61]  M. Hetman,et al.  Survival signaling pathways activated by NMDA receptors. , 2006, Current topics in medicinal chemistry.

[62]  T. Ogihara,et al.  Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. , 2006, Biochemical and biophysical research communications.

[63]  Y. A. Wang.  Klotho, the long sought-after elixir and a novel tumor suppressor? , 2006, Cancer biology & therapy.

[64]  T. Suga,et al.  Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice , 2005, Mechanisms of Ageing and Development.

[65]  K. Rosenblatt,et al.  Regulation of Oxidative Stress by the Anti-aging Hormone Klotho*♦ , 2005, Journal of Biological Chemistry.

[66]  Animesh Nandi,et al.  Suppression of Aging in Mice by the Hormone Klotho , 2005, Science.

[67]  F. Alameda,et al.  Tissue plasminogen activator mediates amyloid‐induced neurotoxicity via Erk1/2 activation , 2005, The EMBO journal.

[68]  Elias S. J. Arnér,et al.  Measurement of Thioredoxin and Thioredoxin Reductase , 2005, Current protocols in toxicology.

[69]  K. Maiese,et al.  Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease , 2005, Progress in Neurobiology.

[70]  M. Mirault,et al.  Emerging roles of thioredoxin cycle enzymes in the central nervous system , 2005, Cellular and Molecular Life Sciences CMLS.

[71]  H. Yamada,et al.  Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. , 2004, Cell structure and function.

[72]  P. Greengard,et al.  Pharmacological inhibitors of glycogen synthase kinase 3. , 2004, Trends in pharmacological sciences.

[73]  K. Maiese,et al.  The NAD+ Precursor Nicotinamide Governs Neuronal Survival During Oxidative Stress Through Protein Kinase B Coupled to FOXO3a and Mitochondrial Membrane Potential , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[74]  K. Maiese,et al.  AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9. , 2004, Experimental cell research.

[75]  K. Maiese,et al.  Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity , 2003, Journal of neuroscience research.

[76]  K. Maiese,et al.  Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. , 2003, Molecular pharmacology.

[77]  J. Ji,et al.  Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins , 2003, International Journal of Developmental Neuroscience.

[78]  H. Braak,et al.  Role of protein kinase B in Alzheimer's neurofibrillary pathology , 2003, Acta Neuropathologica.

[79]  Gert Lubec,et al.  Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders , 2003, Brain Research.

[80]  T. Nabeshima,et al.  Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  Jon W. Johnson,et al.  Persistent Activation of ERK Contributes to Glutamate-induced Oxidative Toxicity in a Neuronal Cell Line and Primary Cortical Neuron Cultures* , 2000, The Journal of Biological Chemistry.

[82]  R. Nagai,et al.  Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. , 1998, Biochemical and biophysical research communications.

[83]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[84]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[85]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[86]  Y. Nabeshima,et al.  A stable cellular marker for the analysis of mouse chimeras: the bacterial chloramphenicol acetyltransferase gene driven by the human elongation factor 1 alpha promoter. , 1991, Differentiation; research in biological diversity.

[87]  D. W. Kim,et al.  Use of the human elongation factor 1α promoter as a versatile and efficient expression system , 1990 .

[88]  S. Nagata,et al.  Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. , 1989, The Journal of biological chemistry.

[89]  L. Mucke,et al.  Life Extension Factor Klotho Enhances Cognition , 2016 .

[90]  M. Glicksman,et al.  Identification of novel small molecules that elevate Klotho expression. , 2012, The Biochemical journal.

[91]  L. Jungbauer,et al.  Preparing synthetic Aβ in different aggregation states. , 2011, Methods in molecular biology.

[92]  Chang-Ping Hu,et al.  Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[93]  D. Rosene,et al.  Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey , 2008, Glia.

[94]  F. Holsboer,et al.  Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. , 1997, Endocrinology.